Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889541 | 0.93 | CASR (0.32) | CASRDNMT1 | |
| SCHEMBL12570234 | 0.92 | CASR (0.31) | CASRDNMT1 | |
| SCHEMBL888067 | 0.92 | CASR (0.31) | CASRDNMT1 | |
| SCHEMBL16728029 | 0.86 | DNMT1 (0.31) | DNMT1 | |
| SCHEMBL14680042 | 0.86 | DNMT1 (0.31) | DNMT1 | |
| SCHEMBL14680063 | 0.85 | DNMT1 (0.31) | DNMT1 | |
| SCHEMBL16728043 | 0.85 | DNMT1 (0.31) | DNMT1 | |
| SCHEMBL10178355 | 0.85 | TOP2A (0.30) | DNMT1 | |
| SCHEMBL19033147 | 0.85 | DNMT1 (0.36) | DNMT1 | |
| SCHEMBL10178004 | 0.84 | TOP2A (0.30) | DNMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969535-B2 | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | LASERGEN, INC. (US) | 2015-03-03 | — | — | US | disclosed |
| US-20130072388-A1 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN IN DNA SEQUENCING | AGILENT TECHNOLOGIES, INC. | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072388-A1 | PHOTOCLEAVABLE LABELED NUCLEOTIDES AND NUCLEOSIDES AND METHODS FOR THEIR USE IN IN DNA SEQUENCING | UNG, NT5C3B, OGG1 | CASR 2456/4885DNMT1 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.